Summit Therapeutics SMMT
NASDAQ SMMT
$15.55 -0.28 (-1.77%)
At close: Oct 22, 2026 · 4:00 PM EDT

Summit Therapeutics (SMMT) Short-term Investments (2023 - 2026)

Updated

Summit Therapeutics (SMMT) recorded Short-term Investments of $271.31 million in Q2 2026, down 44.9% from the prior quarter.

Analysis

Summit Therapeutics (SMMT) Short-term Investments (2023 - 2026) Analysis & Trends

At the end of FY2025, Summit Therapeutics reported Short-term Investments of $488.18 million, up 58.8% from FY2024.

  • Across earlier years, Short-term Investments came in at $307.49 million in FY2024 (+167.8%) and $114.82 million in FY2023.
  • The Q2 2026 figure is the lowest quarterly Short-term Investments since Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn
10 Summit Therapeutics 11.90 Bn 9.66 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 271.31 Mn
Mar 31, 2026 492.22 Mn
Dec 31, 2025 488.18 Mn
Mar 31, 2025 149.79 Mn
Dec 31, 2024 307.49 Mn
Sep 30, 2024 393.12 Mn
Jun 30, 2024 297.04 Mn
Mar 31, 2024 95.39 Mn
Dec 31, 2023 114.82 Mn
Sep 30, 2023 175.15 Mn
Jun 30, 2023 172.90 Mn
Mar 31, 2023 170.96 Mn
API Access

Summit Therapeutics Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=SMMT&period=max&api_key=YOUR_API_KEY